• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Artificial Intelligence

Large language models (LLMs) demonstrated the ability to generate accurate research manuscripts but required human oversight for more complex analyses

byCheng En Xi
September 24, 2026
in Artificial Intelligence, Preclinical
Reading Time: 2 mins read
Share on FacebookShare on Twitter

1. Ifargan and colleagues developed a platform that guides LLMs to annotate research data and produce comprehensive research papers.

2. The platform demonstrated reliability for simpler tasks, such as creating research papers. Human intervention remained critical as data complexity increased.

Evidence Rating Level: 3 (Average)

Study Rundown: Conducting research and compiling results is challenging and labor-intensive. LLMs have recently shown they can design and run experiments, but their ability to produce accurate findings while maintaining scientific transparency remains uncertain. Ifargan and colleagues developed an automation platform that systemically guides LLMs to complete research manuscripts using annotated data. The platform formulates hypotheses, develops and executes analysis code, interprets findings, and writes papers, either autonomously or with human feedback. The platform’s performance across five case studies involving different fields was evaluated. The primary outcomes included the correctness of analyses and interpretations, reproduction of published findings, and traceability of reported results. The study found that 8 of the 10 manuscripts generated autonomously from two relatively simple datasets contained no major errors. However, the platform’s performance deteriorated with more complex datasets or broader research objectives, and targeted human feedback was required to correct these errors. This study demonstrated that artificial intelligence (AI) could produce traceable research manuscripts from less complex data, but oversight for more complex analyses is still needed.

Click here to read the study in NEJM AI

Relevant Reading: The Future of Research in an Artificial Intelligence-Driven World

RELATED REPORTS

Artificial intelligence (AI)-triggered rapid response notifications were associated with lower mortality among inpatients

Deep-learning model achieved high diagnostic performance for detecting cardiac enlargement using electrocardiograms

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

In-Depth [case series]: This study evaluated a 17-step workflow using ChatGPT-family models. Two modes were examined in the study: an Autopilot mode that proceeded without human feedback and a Copilot mode that incorporated reviewer comments. The platform’s performance across the following fields was evaluated: health indicators, social networks, infections, neonatal treatment policy, and pediatric intubation. During initial testing, five manuscripts were generated from a health-indicator dataset, and another five were generated from a congressional social-network dataset. Researchers manually reviewed analysis code and manuscript text for major errors, imperfections, and correct interpretations. The primary outcomes included the correctness of analyses and interpretations, reproduction of published findings, and traceability of reported results. The platform correctly reproduced their analysis outputs in tables, with 8 of the 10 manuscripts containing no major errors. Four autonomous analyses using a more complex longitudinal infection dataset led to major data-handling errors that required human feedback. In ten neonatal treatment-policy analyses, all were reproduced correctly, but two papers contained interpretation errors. For analyses involving pediatric intubations, the broad research task produced a 90% error rate. This study was limited by the small number of selected case studies and dependence on expert feedback. Overall, this study demonstrated that AI has the potential to accelerate biomedical research, but human oversight remains crucial to ensure accuracy.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: artificial intelligencelanguagelargelarge language modelsresearch
Previous Post

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

Next Post

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

RelatedReports

Artificial Intelligence

Artificial intelligence (AI)-triggered rapid response notifications were associated with lower mortality among inpatients

October 2, 2026
Artificial Intelligence

Deep-learning model achieved high diagnostic performance for detecting cardiac enlargement using electrocardiograms

October 1, 2026
A collection of symbolic items such as a microscope
Artificial Intelligence

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

September 30, 2026
Artificial Intelligence

An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis

September 25, 2026
Next Post

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis

Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The Scan by 2 Minute Medicine®: Sugary drinks track with higher depression risk while coffee shows the opposite, US measles cases reach their highest level in decades, peptide injections fuel the next wellness craze, and most routine blood tests do not require prolonged fasting
  • Earlier menopause is associated with faster cognitive decline and greater late-life brain changes
  • Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.